12:00 AM
 | 
Nov 08, 1999
 |  BC Week In Review  |  Company News  |  Deals

Vical, Merck deal

VICL received a $2 million payment from partner Merck that extends Merck's exclusive worldwide rights to use VICL's naked...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >